{
    "info": {
        "nct_id": "NCT03435081",
        "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis",
        "inclusion_criteria": "* Have a diagnosis of atopic dermatitis (AD) at least 12 months before screening.\n* Have moderate to severe AD, including all of the following:\n\n  * EASI score ≥16\n  * IGA score of ≥3\n  * ≥10% of BSA involvement\n* Have had inadequate response or intolerance to existing topical (applied to the skin) medications within 6 months preceding screening.\n* Are willing to discontinue certain treatments for eczema (such as systemic and topical treatments during a washout period).\n* Agree to use emollients daily.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Are currently experiencing or have a history of other concomitant skin conditions (e.g., psoriasis or lupus erythematosus), or a history of erythrodermic, refractory, or unstable skin disease that requires frequent hospitalizations and/or intravenous treatment for skin infections.\n* A history of eczema herpeticum within 12 months, and/or a history of 2 or more episode of eczema herpeticum in the past.\n* Participants who are currently experiencing a skin infection that requires treatment, or is currently being treated, with topical or systemic antibiotics.\n* Have any serious illness that is anticipated to require the use of systemic corticosteroids or otherwise interfere with study participation or require active frequent monitoring (e.g., unstable chronic asthma).\n* Have been treated with the following therapies:\n\n  * monoclonal antibody for less than 5 half-lives before randomization\n  * received prior treatment with any oral Janus kinase (JAK) inhibitor less than 4 weeks before randomization\n  * received any parenteral corticosteroid administered by intramuscular or intravenous injection within 6 weeks of planned randomization or are anticipated to require parenteral injection of corticosteroids during the study\n  * have had an intra-articular corticosteroid injection within 6 weeks of planned randomization\n  * probenecid at the time of randomization that cannot be discontinued for the duration of the study\n* Have high blood pressure characterized by a repeated systolic blood pressure >160 millimeters of mercury (mm Hg) or diastolic blood pressure >100 mm Hg.\n* Have had major surgery within the past eight weeks or are planning major surgery during the study.\n* Have experienced any of the following within 12 weeks of screening: myocardial infarction (MI), unstable ischemic heart disease, stroke, or New York Heart Association Stage III/IV heart failure.\n* Have a history of venous thromboembolic event (VTE), or are considered at high risk for VTE.\n* Have a history or presence of cardiovascular, respiratory, hepatic, chronic liver disease gastrointestinal, endocrine, hematological, neurological, lymphoproliferative disease or neuropsychiatric disorders or any other serious and/or unstable illness.\n* Have a current or recent clinically serious viral, bacterial, fungal, or parasitic infection including herpes zoster, tuberculosis.\n* Have specific laboratory abnormalities.\n* Have received certain treatments that are contraindicated.\n* Pregnant or breastfeeding.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* IGA score of ≥3",
            "criterions": [
                {
                    "exact_snippets": "IGA score of ≥3",
                    "criterion": "IGA score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have moderate to severe AD, including all of the following:",
            "criterions": [
                {
                    "exact_snippets": "Have moderate to severe AD",
                    "criterion": "atopic dermatitis (AD)",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "including all of the following:",
                    "criterion": "additional atopic dermatitis (AD) features",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have a diagnosis of atopic dermatitis (AD) at least 12 months before screening.",
            "criterions": [
                {
                    "exact_snippets": "Have a diagnosis of atopic dermatitis (AD)",
                    "criterion": "atopic dermatitis diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 12 months before screening",
                    "criterion": "duration of atopic dermatitis diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ≥10% of BSA involvement",
            "criterions": [
                {
                    "exact_snippets": "≥10% of BSA involvement",
                    "criterion": "body surface area (BSA) involvement",
                    "requirements": [
                        {
                            "requirement_type": "extent",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "% of BSA"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have had inadequate response or intolerance to existing topical (applied to the skin) medications within 6 months preceding screening.",
            "criterions": [
                {
                    "exact_snippets": "inadequate response or intolerance to existing topical (applied to the skin) medications within 6 months preceding screening",
                    "criterion": "response to topical medications",
                    "requirements": [
                        {
                            "requirement_type": "response",
                            "expected_value": "inadequate"
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months preceding screening"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "inadequate response or intolerance to existing topical (applied to the skin) medications within 6 months preceding screening",
                    "criterion": "tolerance to topical medications",
                    "requirements": [
                        {
                            "requirement_type": "tolerance",
                            "expected_value": "intolerance"
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months preceding screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* EASI score ≥16",
            "criterions": [
                {
                    "exact_snippets": "EASI score ≥16",
                    "criterion": "EASI score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 16,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Agree to use emollients daily.",
            "criterions": [
                {
                    "exact_snippets": "Agree to use emollients daily",
                    "criterion": "emollient use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "frequency",
                            "expected_value": "daily"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Are willing to discontinue certain treatments for eczema (such as systemic and topical treatments during a washout period).",
            "criterions": [
                {
                    "exact_snippets": "willing to discontinue certain treatments for eczema (such as systemic and topical treatments during a washout period)",
                    "criterion": "willingness to discontinue eczema treatments",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "systemic",
                                "topical"
                            ]
                        },
                        {
                            "requirement_type": "washout period",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Have been treated with the following therapies:",
            "criterions": [
                {
                    "exact_snippets": "Have been treated with the following therapies",
                    "criterion": "prior therapies",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have any serious illness that is anticipated to require the use of systemic corticosteroids or otherwise interfere with study participation or require active frequent monitoring (e.g., unstable chronic asthma).",
            "criterions": [
                {
                    "exact_snippets": "Have any serious illness that is anticipated to require the use of systemic corticosteroids",
                    "criterion": "serious illness",
                    "requirements": [
                        {
                            "requirement_type": "anticipated need for systemic corticosteroids",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious illness that is anticipated to ... otherwise interfere with study participation",
                    "criterion": "serious illness",
                    "requirements": [
                        {
                            "requirement_type": "interference with study participation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious illness that is anticipated to ... require active frequent monitoring (e.g., unstable chronic asthma)",
                    "criterion": "serious illness",
                    "requirements": [
                        {
                            "requirement_type": "requirement for active frequent monitoring",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Are currently experiencing or have a history of other concomitant skin conditions (e.g., psoriasis or lupus erythematosus), or a history of erythrodermic, refractory, or unstable skin disease that requires frequent hospitalizations and/or intravenous treatment for skin infections.",
            "criterions": [
                {
                    "exact_snippets": "currently experiencing or have a history of other concomitant skin conditions (e.g., psoriasis or lupus erythematosus)",
                    "criterion": "concomitant skin conditions",
                    "requirements": [
                        {
                            "requirement_type": "presence or history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of erythrodermic, refractory, or unstable skin disease",
                    "criterion": "erythrodermic, refractory, or unstable skin disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "skin disease that requires frequent hospitalizations and/or intravenous treatment for skin infections",
                    "criterion": "skin disease requiring frequent hospitalizations or intravenous treatment for skin infections",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": [
                                "frequent hospitalizations",
                                "intravenous treatment for skin infections"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants who are currently experiencing a skin infection that requires treatment, or is currently being treated, with topical or systemic antibiotics.",
            "criterions": [
                {
                    "exact_snippets": "currently experiencing a skin infection",
                    "criterion": "skin infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requires treatment, or is currently being treated, with topical or systemic antibiotics",
                    "criterion": "treatment with topical or systemic antibiotics for skin infection",
                    "requirements": [
                        {
                            "requirement_type": "requirement for treatment",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "currently being treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have a history of venous thromboembolic event (VTE), or are considered at high risk for VTE.",
            "criterions": [
                {
                    "exact_snippets": "Have a history of venous thromboembolic event (VTE)",
                    "criterion": "venous thromboembolic event (VTE) history",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "are considered at high risk for VTE",
                    "criterion": "venous thromboembolic event (VTE) risk",
                    "requirements": [
                        {
                            "requirement_type": "risk",
                            "expected_value": "high"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* probenecid at the time of randomization that cannot be discontinued for the duration of the study",
            "criterions": [
                {
                    "exact_snippets": "probenecid at the time of randomization that cannot be discontinued for the duration of the study",
                    "criterion": "probenecid use",
                    "requirements": [
                        {
                            "requirement_type": "use at time of randomization",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability to discontinue for duration of study",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* received any parenteral corticosteroid administered by intramuscular or intravenous injection within 6 weeks of planned randomization or are anticipated to require parenteral injection of corticosteroids during the study",
            "criterions": [
                {
                    "exact_snippets": "received any parenteral corticosteroid administered by intramuscular or intravenous injection within 6 weeks of planned randomization",
                    "criterion": "parenteral corticosteroid administration",
                    "requirements": [
                        {
                            "requirement_type": "route",
                            "expected_value": [
                                "intramuscular",
                                "intravenous"
                            ]
                        },
                        {
                            "requirement_type": "time since last administration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "are anticipated to require parenteral injection of corticosteroids during the study",
                    "criterion": "anticipated need for parenteral corticosteroid injection",
                    "requirements": [
                        {
                            "requirement_type": "anticipated requirement during study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have a current or recent clinically serious viral, bacterial, fungal, or parasitic infection including herpes zoster, tuberculosis.",
            "criterions": [
                {
                    "exact_snippets": "current or recent clinically serious viral, bacterial, fungal, or parasitic infection",
                    "criterion": "clinically serious infection",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "viral",
                                "bacterial",
                                "fungal",
                                "parasitic"
                            ]
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": "current or recent"
                        }
                    ]
                },
                {
                    "exact_snippets": "including herpes zoster, tuberculosis",
                    "criterion": "specific infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": [
                                "herpes zoster",
                                "tuberculosis"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have received certain treatments that are contraindicated.",
            "criterions": [
                {
                    "exact_snippets": "Have received certain treatments that are contraindicated",
                    "criterion": "receipt of contraindicated treatments",
                    "requirements": [
                        {
                            "requirement_type": "history of receipt",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraindication status",
                            "expected_value": "contraindicated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* monoclonal antibody for less than 5 half-lives before randomization",
            "criterions": [
                {
                    "exact_snippets": "monoclonal antibody for less than 5 half-lives before randomization",
                    "criterion": "monoclonal antibody administration",
                    "requirements": [
                        {
                            "requirement_type": "time since last administration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5,
                                "unit": "half-lives"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* received prior treatment with any oral Janus kinase (JAK) inhibitor less than 4 weeks before randomization",
            "criterions": [
                {
                    "exact_snippets": "received prior treatment with any oral Janus kinase (JAK) inhibitor",
                    "criterion": "prior treatment with oral Janus kinase (JAK) inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "less than 4 weeks before randomization",
                    "criterion": "time since prior treatment with oral Janus kinase (JAK) inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have high blood pressure characterized by a repeated systolic blood pressure >160 millimeters of mercury (mm Hg) or diastolic blood pressure >100 mm Hg.",
            "criterions": [
                {
                    "exact_snippets": "high blood pressure characterized by a repeated systolic blood pressure >160 millimeters of mercury (mm Hg)",
                    "criterion": "systolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "repeated measurement",
                            "expected_value": {
                                "operator": ">",
                                "value": 160,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "high blood pressure characterized by a repeated ... diastolic blood pressure >100 mm Hg",
                    "criterion": "diastolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "repeated measurement",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have had major surgery within the past eight weeks or are planning major surgery during the study.",
            "criterions": [
                {
                    "exact_snippets": "Have had major surgery within the past eight weeks",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "history within timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 8,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "planning major surgery during the study",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "planned during study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have experienced any of the following within 12 weeks of screening: myocardial infarction (MI), unstable ischemic heart disease, stroke, or New York Heart Association Stage III/IV heart failure.",
            "criterions": [
                {
                    "exact_snippets": "myocardial infarction (MI) ... within 12 weeks of screening",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable ischemic heart disease ... within 12 weeks of screening",
                    "criterion": "unstable ischemic heart disease",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "stroke ... within 12 weeks of screening",
                    "criterion": "stroke",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "New York Heart Association Stage III/IV heart failure ... within 12 weeks of screening",
                    "criterion": "New York Heart Association Stage III/IV heart failure",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have specific laboratory abnormalities.",
            "criterions": [
                {
                    "exact_snippets": "specific laboratory abnormalities",
                    "criterion": "laboratory abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* have had an intra-articular corticosteroid injection within 6 weeks of planned randomization",
            "criterions": [
                {
                    "exact_snippets": "have had an intra-articular corticosteroid injection",
                    "criterion": "intra-articular corticosteroid injection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "within 6 weeks of planned randomization",
                    "criterion": "timing of intra-articular corticosteroid injection",
                    "requirements": [
                        {
                            "requirement_type": "time since injection",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A history of eczema herpeticum within 12 months, and/or a history of 2 or more episode of eczema herpeticum in the past.",
            "criterions": [
                {
                    "exact_snippets": "A history of eczema herpeticum within 12 months",
                    "criterion": "eczema herpeticum",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "a history of 2 or more episode of eczema herpeticum in the past",
                    "criterion": "eczema herpeticum",
                    "requirements": [
                        {
                            "requirement_type": "number_of_episodes",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "episodes"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Have a history or presence of cardiovascular, respiratory, hepatic, chronic liver disease gastrointestinal, endocrine, hematological, neurological, lymphoproliferative disease or neuropsychiatric disorders or any other serious and/or unstable illness.",
            "criterions": [
                {
                    "exact_snippets": "history or presence of cardiovascular ... disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of respiratory ... disease",
                    "criterion": "respiratory disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of hepatic ... disease",
                    "criterion": "hepatic disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of chronic liver disease",
                    "criterion": "chronic liver disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of gastrointestinal ... disease",
                    "criterion": "gastrointestinal disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of endocrine ... disease",
                    "criterion": "endocrine disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of hematological ... disease",
                    "criterion": "hematological disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of neurological ... disease",
                    "criterion": "neurological disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of lymphoproliferative disease",
                    "criterion": "lymphoproliferative disease",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history or presence of neuropsychiatric disorders",
                    "criterion": "neuropsychiatric disorders",
                    "requirements": [
                        {
                            "requirement_type": "history or presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any other serious and/or unstable illness",
                    "criterion": "serious and/or unstable illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}